Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement

Authors

Michael J. Barry, Harvard Medical School, Boston, Massachusetts.
Wanda K. Nicholson, George Washington University, Washington, DC.
Michael Silverstein, Brown University, Providence, Rhode Island.
Michael D. Cabana, Albert Einstein College of Medicine, New York, New York.
David Chelmow, Virginia Commonwealth University, Richmond.
Tumaini Rucker Coker, University of Washington, Seattle.
Esa M. Davis, University of Maryland School of Medicine, Baltimore.
Katrina E. Donahue, University of North Carolina at Chapel Hill.
Carlos Roberto Jaén, University of Texas Health Science Center, San Antonio.
Li Li, University of Virginia, Charlottesville.
Gbenga Ogedegbe, New York University, New York, New York.
Goutham Rao, Case Western Reserve University, Cleveland, Ohio.
John M. Ruiz, University of Arizona, Tucson.
James Stevermer, University of Missouri, Columbia.
Joel Tsevat, University of Texas Health Science Center, San Antonio.
Sandra Millon Underwood, University of Wisconsin, Milwaukee.
John B. Wong, Tufts University School of Medicine, Boston, Massachusetts.

Document Type

Journal Article

Publication Date

9-19-2023

Journal

JAMA

Volume

330

Issue

11

DOI

10.1001/jama.2023.16991

Abstract

IMPORTANCE: Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10 000 deliveries in 1993 to 1021 cases per 10 000 deliveries in 2016 to 2017. OBJECTIVE: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy. POPULATION: Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension. EVIDENCE ASSESSMENT: The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit. RECOMMENDATION: The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation).

APA Citation

Barry, Michael J.; Nicholson, Wanda K.; Silverstein, Michael; Cabana, Michael D.; Chelmow, David; Coker, Tumaini Rucker; Davis, Esa M.; Donahue, Katrina E.; Jaén, Carlos Roberto; Li, Li; Ogedegbe, Gbenga; Rao, Goutham; Ruiz, John M.; Stevermer, James; Tsevat, Joel; Underwood, Sandra Millon; and Wong, John B., "Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement" (2023). GW Authored Works. Paper 3383.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/3383

Department

Prevention and Community Health